DOCS R&D to Revenue
Doximity, Inc. Class A Common Stock · R&D to Revenue
DOCS R&D to Revenue
Latest reported24.57%period ending
DOCS Quarterly R&D/Revenue (26.54% → 24.57%)
Latest values, visible window
High-resolution chart · PNG
DOCS r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 24.5674% | |
| 26.9006% | |
| 18.6946% | |
| 17.9214% | |
| 18.3664% | |
| 17.9358% | |
| 13.2981% | |
| 16.9843% | |
| 17.8203% | |
| 17.0663% | |
| 14.7438% | |
| 17.5668% | |
| 20.2187% | |
| 19.4123% | |
| 17.8021% | |
| 18.6955% | |
| 20.9866% | |
| 18.6048% | |
| 16.5771% | |
| 19.4833% | |
| 18.221% | |
| 18.8313% | |
| 19.428% | |
| 21.8695% | |
| 27.5998% | |
| 24.4567% | |
| 26.5373% |